Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.30
-0.0100-0.76%
Volume:107.27K
Turnover:143.74K
Market Cap:8.66M
PE:-0.27
High:1.40
Open:1.35
Low:1.28
Close:1.31
52wk High:11.40
52wk Low:0.6201
Shares:6.66M
Float Shares:6.00M
Volume Ratio:0.64
T/O Rate:1.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7656
EPS(LYR):-8.3501
ROE:-660.08%
ROA:-95.77%
PB:1.87
PE(LYR):-0.16

Loading ...

Fibrobiologics Faces NASDAQ Delisting After Bid Price Stays Below $1

Reuters
·
Jul 25

Fibrobiologics Director Kathleen Hallisey Rubins Files Initial Beneficial Ownership Statement

Reuters
·
Jul 17

Fibrobiologics - Registers Resale of up to 12.53 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jul 10

FibroBiologics Appoints NASA Scientist Kate Rubins to Board

TIPRANKS
·
Jul 09

Fibrobiologics Appoints Ex-nasa Astronaut Kate Rubins to Board

Reuters
·
Jul 09

Fibrobiologics Appoints Kathleen "kate" Rubins, Ph.d. to Board of Directors

THOMSON REUTERS
·
Jul 09

Fibrobiologics - Expects Cost Savings by Eliminating Additional Vial Manufacturing

THOMSON REUTERS
·
Jul 07

Fibrobiologics - Expects Sufficient Cywc628 Supply to Complete Dfu Clinical Trial

THOMSON REUTERS
·
Jul 07

Fibrobiologics Completes Manufacturing of Third Batch of Cywc628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

THOMSON REUTERS
·
Jul 07

FibroBiologics Secures New Private Placement Financing

TIPRANKS
·
Jun 30

Fibrobiologics Closes Private Placement Priced at USD 0.735 Per Share, Raises USD 3 Million Upfront

Reuters
·
Jun 30

Fibrobiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-market Under NASDAQ Rules

THOMSON REUTERS
·
Jun 30

FibroBiologics announces $9M private placement priced at-the-market

TIPRANKS
·
Jun 26

Fibrobiologics Prices Unregistered $3 Million Share Private Placement at $0.735 Per Share

Reuters
·
Jun 26

Press Release: Fibrobiologics Announces up to $9.0 Million Private Placement Priced At-the-market Under NASDAQ Rules

Dow Jones
·
Jun 26

FibroBiologics Shareholders Approve New 2026 Equity Plan

TIPRANKS
·
Jun 24

FibroBiologics shareholders approve 2026 equity incentive plan at annual meeting

Reuters
·
Jun 24

Fibrobiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

THOMSON REUTERS
·
Jun 22

FibroBiologics gets USPTO notice of allowance for topical fibroblast spheroid wound-healing patent application

Reuters
·
Jun 22

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

GlobeNewswire
·
Jun 22